Contact Information

Call: (+61) 425-716-347

Email: Seyed.tamehrizadeh@research.uwa.edu.au

Seyed Saeed Tamehri Zadeh

University of Western Australia (UWA)
PhD (Medicine)
Thesis: Clinical Studies in Inherited Hypercholesteremia
Doctoral supervisor: Professor Gerald F Watts

 

Education

  • 2024- University of Western Australia (UWA) PhD (Medicine) Thesis: Clinical Studies in Inherited Hypercholesteremia
    Doctoral supervisor: Professor Gerald F Watts
  • 2012-2019 Tehran University of Medical Sciences (TUMS)
    Doctor of Medicine

Awards and Accreditation

  • 2024 The UWA international Fee Scholarship to cover tuition and OSHC (57 months)
  • 2024 The Australian Government Research Training Program Stipend Scholarship to cover a living allowance (3.5 years)
  • 2018 Ranked 6th in the Pre-internship Exam among over 3,000 medical students
  • 2012 Ranked 9th among near 400,000 participants in the National University Entrance Exam

Clinical experience and skills training as a M.D

Rotated through all major and minor specialties, including emergency medicine, internal medicine (cardiology, nephrology, endocrinology, hematology, rheumatology, gastroenterology, pulmonology) obstetrics and gynecology, pediatrics, surgery, otorhinolaryngology, infectious diseases, and psychiatry. Visited patients independently in different hospitals, prescribed treatments for patients, and they have several night shifts in every rotation to competently implement all the skills learned. Communicated with patients, took a history, examined patients, took on- and off-service notes for in-patients, requested relevant blood tests (hematology, biochemistry, microbiology, virology, immunology), different imaging modalities, like CT scan or MRI, performing CPR, and several procedures.

Employment history

  • 2018-2024 Prevention of Metabolic Disorders Research Center, Shahid Beheshti University of Medical Sciences, post-doc fellowship
  • 2021-2023 Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, post-doc fellowship

Research skills & Experience

  • Experience with data management, statistical analyses using statistical software packages (STATA & R & SPSS) and scientific writing
  • Strong analytical abilities and practical experience in quantitative analysis
  • Excellent communication and interpersonal skills which have resulted in positive relations with participants and healthcare professionals
  • Facilitating the establishment of successful research networks and collaborations through effective communication, support, and encouragement
  • Supporting diverse research goals to maximise efficiency and collaboration

Published Works

Scientific articles:

1.Masrouri S, Tamehri Zadeh SS, Tohidi M, Azizi F, Hadaegh F. Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS. Journal of Diabetes Investigation. 2024.
2.Tamehri Zadeh SS, Cheraghloo N, Masrouri S, Esmaeili F, Azizi F, Hadaegh F. Association between metabolic score for insulin resistance and clinical outcomes: insights from the Tehran lipid and glucose study. Nutrition & Metabolism. 2024;21(1):34.
3.Masrouri S, Tamehri Zadeh SS, Afaghi S, Hadaegh F, Khalili D, Shapiro MD: Anthropometric indices in young adulthood predict midlife cardiovascular risk among non-obese individuals without traditional risk factors. Journal of the American Heart Association.
4.Masrouri S, Tamehri Zadeh SS, Shapiro MD, Khalili D, Hadaegh F. Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults. Atherosclerosis.
5.Masrouri S, Tamehri Zadeh SS, Pishgahi M, Azizi F, Shapiro MD and Hadaegh F. Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study. Journal of Nephrology. 2023; 37:1-12.
6.Kabootari M, Tamehri Zadeh SS (co-first), Hasheminia M, Azizi F, Hadaegh F. Change in blood pressure status defined by 2017 ACC/AHA hypertension guideline and risk of cardiovascular disease: results of over a decade of follow-up of the Iranian population. Frontiers in Cardiovascular Medicine. 2023; 10:1044638.
7.Tamehri Zadeh SS, Khajavi A, Tohidi M, Azizi F, Hadaegh F. Impact of short-and long-term exposure to air pollution on lipid profile in adults aged 20 to 69 years in Tehran Province, Iran. Atmospheric Environment. 2023; 306:119796.
8.Deravi N, Sharifi Y, Koohi F, Tamehri Zadeh SS, Masrouri S, Azizi F, et al. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies. BMC Public Health. 2023;23(1):565.
9.Tamehri Zadeh SS, Khajavi A, Ramanathan A, Azizi F, Hadaegh F. The impact of long-term exposure to PM10, SO2, O3, NO2, and CO on incident dysglycemia: a population-based cohort study. Environmental Science and Pollution Research. 2023;30(2):3213.

10.Tamehri Zadeh SS, Moazzeni SS, Asgari S, Mirbolouk M, Azizi F, Hadaegh F. Association between Wrist Circumference and Risk of Any Fracture in Adults: Findings from 15 Years of Follow-Up in the Tehran Lipid and Glucose Study. Journal of Clinical Medicine. 2022;11(23):7048.
11.Ramezankhani A, Habibi-Moeini AS, Tamehri Zadeh SS, Azizi F, Hadaegh F. Effect of family history of diabetes and obesity status on lifetime risk of type 2 diabetes in the Iranian population. Journal of Global Health. 2022;12: 04068.
12.Tamehri Zadeh SS, Moazzeni SS, Matsushita K, Hasheminia M, Azizi F, Hadaegh F. Application of the 2017 American college of cardiology/American Heart Association Blood Pressure Guidelines for cardiovascular outcomes among Tehranian residents. Journal of Hypertension. 2022;40(5):924-32.
13.Sheklabadi E, Sharifi Y, Tabarraee M, Tamehri Zadeh SS, Rabiee P, Hadaegh F. Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review. Thrombosis Journal. 2022;20(1):1-9
14.Chavoshi V, Tamehri Zadeh SS (co-first), Khalili S, Rabbani A, Matini SAH, Mohsenifar Z, et al. long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review. BMC Endocrine Disorders. 2022;22(1):108.
15.Moazzeni SS, Tamehri Zadeh SS (co-first), Asgari S, Azizi F, Hadaegh F. Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study. Diabetology & Metabolic Syndrome. 2021;13(1):1-12.
16.Rahimzadeh H, Tamehri Zadeh SS, Khajavi A, Saatchi M, Reis LO, Guitynavard F, et al. The tsunami of COVID-19 infection among kidney transplant recipients: a single-center study from Iran. Journal of Epidemiology and Global Health. 2021;11(4):389-96.
17.Ahanchi NS, Tamehri Zadeh SS, Khalili D, Azizi F, Hadaegh F. Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study. Journal of Translational Medicine. 2021;19(1):1-12.
18.Khajavi A, Tamehri Zadeh SS (co-first), Azizi F, Brook RD, Abdi H, Zayeri F, et al. Impact of short-and long-term exposure to air pollution on blood pressure: A two-decade population-based study in Tehran. International Journal of Hygiene and Environmental Health. 2021; 234:113719.
19.Qorbani M, Heidari-Beni M, Ejtahed H-S, Shafiee G, Goodarzi F, Tamehri Zadeh SS, et al. Association of vitamin D status and cardio-metabolic risk factors in children and adolescents: the CASPIAN-V study. BMC nutrition. 2021;7(1):71.SS, et al. Association of vitamin D status and cardio-metabolic risk factors in children and adolescents: the CASPIAN-V study. BMC nutrition. 2021;7(1):71.

Reviews and Editorials:

20.Tamehri Zadeh SS, Khalaji Mahla, Tajdari Mobina et al. Statins: Novel Approaches for the Management of Doxorubicin-Induced Cardiotoxicity—A Literature Review. Cardiovascular Toxicology 2025.
21.Tamehri Zadeh SS, Toth PP, Shapiro MD et al. ANGPTL3 vital role in different kidney diseases. Current knowledge and future perspectives. Biomedicine & Pharmacotherapy 2025; 188:118189.
22.Tamehri Zadeh SS, Pang J, Watts GF. Wheels within wheels: Diagnostic and risk modifiers for familial hypercholesterolemia in the community. European Journal of Internal Medicine 2025.
23.Tamehri Zadeh SS, Pang J, Chan DC, Watts GF. A contemporary snapshot of familial hypercholesterolemia registries. Current Opinion in Lipidology. 2024;35(6):297-302.
24.Tamehri Zadeh SS, Shapiro MD. Therapeutic Gene Editing in Dyslipidemias. Reviews in Cardiovascular Medicine. 2024;25(8).
25.Tamehri Zadeh SS, Chan DC, Mata P, Watts GF. Coronary artery event-free or resilient familial hypercholesterolemia: what’s in a name? Current Opinion in Endocrinology, Diabetes and Obesity. 2024:10.1097.
26.Watts GF, Tamehri Zadeh SS, Chan DC: ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesteremia: a shot in the arm for evinacumab. European Heart Journal.
27.Mehraeen E, Abbaspour F, Banach M, SeyedAlinaghi S, Zarebidoki A, Tamehri Zadeh SS (correspondence). The prognostic significance of insulin resistance in COVID-19: a review. Journal of Diabetes & Metabolic Disorders. 2024; : 1-18.
28.Lashgari N-A, Roudsari NM, Tamehri Zadeh SS, Momtaz S, Abbasifard M, Reiner Ž, Abdolghaffari AH, Sahebkar A: Statins block mammalian target of rapamycin pathway: A possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases. Inflammopharmacology 2023, 31:57-75.
29.Fadaei S, Zarepour F, Parvaresh M, Motamedzadeh A, Tamehri Zadeh SS, Sheida A, et al. Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs. Frontiers in Cardiovascular Medicine. 2022;9:1014961.

30.Maleki B, Alani B, Tamehri Zadeh SS, Saadat S, Rajabi A, Ayoubzadeh SMJ, et al. MicroRNAs and exosomes: Cardiac stem cells in heart diseases. Pathology-Research and Practice. 2022; 229:153701.